{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:17Z","timestamp":1792512677517,"version":"4.5.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149686","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T18:45:29Z","timestamp":1456857929000},"page":"e0149686","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Safety of Levetiracetam in Paediatrics: A Systematic Review"],"prefix":"10.1371","volume":"11","author":[{"given":"Oluwaseun","family":"Egunsola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imti","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Mary","family":"Sammons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"WO Pickrell","year":"2014","journal-title":"Seizure"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1007\/s00415-012-6509-3","article-title":"Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany\u2014a nationwide population-based study in children and adults","volume":"259","author":"HM Hamer","year":"2012","journal-title":"J Neurol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2012.02.019","article-title":"Utilization of antiepileptic drugs in Hong Kong children","volume":"46","author":"KL Kwong","year":"2012","journal-title":"Pediatr Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pediatrneurol.2009.08.002","article-title":"Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy","volume":"42","author":"YJ Lee","year":"2010","journal-title":"Pediatr Neurol"},{"key":"ref5","unstructured":"National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. 2012; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/guidance.nice.org.uk\/cg137\" xlink:type=\"simple\">guidance.nice.org.uk\/cg137<\/ext-link>."},{"key":"ref6","unstructured":"UCB Pharma limited. Keppra 250,500,750 and 1000 mg film-coated Tablets, 100 mg\/ml oral solution and 100 mg\/ml concentrate for solution for infusion: Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.medicines.org.uk\/emc\/medicine\/16231\" xlink:type=\"simple\">https:\/\/www.medicines.org.uk\/emc\/medicine\/16231<\/ext-link>."},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of levetiracetam in children","volume":"42","author":"JM Pellock","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"B Abou-Khalil","year":"2008","journal-title":"Neuropsychiatric disease and treatment"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.2196\/jmir.8.4.e25","article-title":"Age-specific search strategies for Medline","volume":"8","author":"M Kastner","year":"2006","journal-title":"J Med Internet Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref11","article-title":"System for the Unified Management of the Review and Assessment of Information (SUMARI)","author":"JB Institute","year":"2004"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejpn.2013.03.014","article-title":"Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: A double-blinded, randomized, controlled trial (German HEAD Study)","volume":"17","author":"I Borggraefe","year":"2013","journal-title":"Europ J Paediatr Neurol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1528-1167.2010.02976.x","article-title":"A multicenter, randomized, placebo\u2010controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy","volume":"52","author":"C Fattore","year":"2011","journal-title":"Epilepsia"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1528-1167.2009.02197.x","article-title":"Neurocognitive effects of adjunctive levetiracetam in children with partial\u2010onset seizures: A randomized, double\u2010blind, placebo\u2010controlled, noninferiority trial","volume":"50","author":"PM Levisohn","year":"2009","journal-title":"Epilepsia"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","article-title":"Adjunctive levetiracetam in infants and young children with refractory partial\u2010onset seizures","volume":"50","author":"JE Pi\u00f1a\u2010Garza","year":"2009","journal-title":"Epilepsia"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"T Glauser","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.braindev.2006.09.008","article-title":"Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial","volume":"29","author":"G Coppola","year":"2007","journal-title":"Brain Dev"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpn.2007.09.004","article-title":"Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study","volume":"12","author":"P Callenbach","year":"2008","journal-title":"Europ J Paediatr Neurol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"KO Nakken","year":"2003","journal-title":"Seizure"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.braindev.2012.07.005","article-title":"Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy","volume":"35","author":"H Kanemura","year":"2013","journal-title":"Brain Dev"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.seizure.2010.12.017","article-title":"A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target","volume":"20","author":"S Chhun","year":"2011","journal-title":"Seizure"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.pediatrneurol.2014.06.004","article-title":"Adjunctive Levetiracetam Treatment in Pediatric Lennox-Gastaut Syndrome","volume":"51","author":"HJ Kim","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and Safety of Levetiracetam in Children with Partial Seizures: An Open\u2010label Trial","volume":"43","author":"TA Glauser","year":"2002","journal-title":"Epilepsia"},{"issue":"3","key":"ref24","first-page":"364","article-title":"Therapeutic effect of levetiracetam add-on treatment for frontal lobe epilepsy in 105 children","volume":"34","author":"Y Zhang","year":"2014","journal-title":"Nan fang yi ke da xue xue bao"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0883073811417183","article-title":"A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures","volume":"27","author":"J Schiemann-Delgado","year":"2012","journal-title":"J Child Neurol"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.seizure.2012.05.010","article-title":"Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children&apos;s hospital","volume":"21","author":"A McTague","year":"2012","journal-title":"Seizure"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1177\/0883073813480241","article-title":"Prospective open-label, single-arm, multicenter, safety, tolerability, and pharmacokinetic studies of Intravenous levetiracetam in children with epilepsy","volume":"28","author":"A Weinstock","year":"2013","journal-title":"J Child Neurol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","article-title":"Levetiracetam in the treatment of neonatal seizures: a pilot study","volume":"19","author":"A F\u00fcrwentsches","year":"2010","journal-title":"Seizure"},{"issue":"4","key":"ref29","first-page":"324","article-title":"Long-term efficacy and tolerability of levetiracetam in different age groups of children with epilepsy: a 210 cases report","volume":"39","author":"XF Feng","year":"2014","journal-title":"Medical Journal of Chinese People's Liberation Army"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.seizure.2006.12.006","article-title":"Levetiracetam monotherapy for children and adolescents with benign rolandic seizures","volume":"16","author":"A Verrotti","year":"2007","journal-title":"Seizure"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0404.2009.01264.x","article-title":"Levetiracetam monotherapy for childhood occipital epilepsy of gastaut","volume":"120","author":"A Verrotti","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"ref32","first-page":"711","article-title":"Follow-up study on levetiracetam monotherapy in children with epilepsy","volume":"10","author":"Z Gao","year":"2008","journal-title":"Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.seizure.2006.02.013","article-title":"Cognitive side effects of anti-epileptic drugs: the relevance in childhood epilepsy","volume":"15","author":"L Lagae","year":"2006","journal-title":"Seizure"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpn.2013.07.003","article-title":"Continuation rates of levetiracetam in children from the EULEVp cohort study","volume":"18","author":"C Dureau-Pournin","year":"2014","journal-title":"Europ J Paediatr Neurol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0883073809348795","article-title":"Intravenous levetiracetam in children with seizures: a prospective safety study","volume":"25","author":"Y-t Ng","year":"2010","journal-title":"J Child Neurol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: safety and efficacy in neonatal seizures","volume":"15","author":"G Ramantani","year":"2011","journal-title":"Europ J Paediatr Neurol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.braindev.2010.03.002","article-title":"Efficacy and tolerability of levetiracetam in children with epilepsy","volume":"33","author":"J Li","year":"2011","journal-title":"Brain Dev"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/pbc.24371","article-title":"Drug\u2013drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia","volume":"60","author":"AS Parentelli","year":"2013","journal-title":"Pediatric blood & cancer"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.seizure.2014.06.004","article-title":"Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review","volume":"23","author":"E Halma","year":"2014","journal-title":"Seizure"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"e007711","DOI":"10.1136\/bmjopen-2015-007711","article-title":"Safety of lamotrigine in paediatrics: a systematic review","volume":"5","author":"O Egunsola","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"JA Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yebeh.2003.12.005","article-title":"Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects","volume":"5","author":"E Brodtkorb","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"e008298","DOI":"10.1136\/bmjopen-2015-008298","article-title":"A prospective study of adverse drug reactions to antiepileptic drugs in children","volume":"5","author":"M Anderson","year":"2015","journal-title":"BMJ Open"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00541291","article-title":"Psychomotor impairment and anticonvulsant therapy in adult epileptic patients","volume":"31","author":"M Brodie","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.yebeh.2003.07.008","article-title":"Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases","volume":"4","author":"V Dinkelacker","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.WNL.0000091865.46063.67","article-title":"Discontinuation of levetiracetam because of behavioral side effects A case-control study","volume":"61","author":"J White","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/adc.2009.165902","article-title":"A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period","volume":"95","author":"M Anderson","year":"2010","journal-title":"Arch Dis Child"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:37:36Z","timestamp":1588966656000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149686"}},"subtitle":[],"editor":[{"given":"Thimmasettappa","family":"Thippeswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149686","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}